Illumina Inc is a global leader in genomics, offering advanced solutions for DNA sequencing and analysis. Based in San Diego, California, since 1998, Illumina provides a wide range of products, including sequencing and array-based instruments, consumables, and whole-genome sequencing kits. These products cater to genomic research centers, academic institutions, hospitals, and various companies in the biotech and pharmaceutical sectors. Illumina is also pioneering in cancer diagnostics with its multi-cancer early detection test, Galleri, and is developing new technologies for blood-based disease detection and monitoring.